Eli Lilly and Co

LLY

Company Profile

  • Business description

    Eli Lilly is a drug firm with a focus on neuroscience, cardiometabolic, cancer, and immunology. Lilly's key products include Verzenio for cancer; Mounjaro, Zepbound, Jardiance, Trulicity, Humalog, and Humulin for cardiometabolic; and Taltz and Olumiant for immunology.

  • Contact

    Lilly Corporate Center
    IndianapolisIN46285
    USA

    T: +1 317 276-2000

    E: [email protected]

    https://www.lilly.com

  • Sector

    Healthcare

    Stock type

    Defensive

  • Industry

    Drug Manufacturers - General

    Fiscal Year End

    31 December 2025

    Employees

    47,000

Eli Lilly and Co News & Analysis

markets

June 2025 US stock market outlook: Has the storm passed?

Be wary of the recent complacency; there’s turbulent water ahead before the skies clear.
markets

US stock market outlook: Where we see opportunities in Q2

A bear market in AI stocks leads to more attractive valuations.
personal-finance

US stock market outlook: tariffs are 2025's wild card

Macrodynamic tailwinds persist, but stocks are already priced to perfection. Will tariffs derail the market in 2025?

Morningstar Investment Ideas

Markets

Index
Last price
Change
% Change
All Ordinaries8,930.4049.00-0.55%
CAC 407,818.2832.15-0.41%
DAX 4024,295.9355.110.23%
Dow JONES (US)44,693.91316.38-0.70%
FTSE 1009,138.3776.880.85%
HKSE25,534.92132.26-0.52%
NASDAQ21,057.9637.940.18%
Nikkei 22541,580.12246.22-0.59%
NZX 50 Index12,848.2643.130.34%
S&P 5006,363.354.440.07%
S&P/ASX 2008,660.6048.80-0.56%
SSE Composite Index3,603.282.45-0.07%

Market Movers